Načítá se...
The use of hybrid Virus-like Particles to enhance the immunogenicity of a broadly protective HPV vaccine
Virus-like particles (VLPs) can serve as a highly immunogenic vaccine platform for the multivalent display of epitopes from pathogens. We have used bacteriophage VLPs to develop vaccines that target a highly conserved epitope from the Human Papillomavirus (HPV) minor capsid protein, L2. VLPs display...
Uloženo v:
| Vydáno v: | Biotechnol Bioeng |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4410690/ https://ncbi.nlm.nih.gov/pubmed/24917327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bit.25311 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|